UVA Health: Enhanced Melanoma Vaccine Offers Improved Survival for Men
March 28, 2024
March 28, 2024
CHARLOTTESVILLE, Virginia, March 28 (TNSres) -- University of Virginia Health issued the following news release:
A second-generation melanoma vaccine developed at UVA Cancer Center improves long-term survival for melanoma patients compared with the first-generation vaccine, new research shows. Interestingly, the benefit of the second-generation vaccine was greater for male patients than female patients. That finding could have important implications for other cancer vaccines, the re . . .
A second-generation melanoma vaccine developed at UVA Cancer Center improves long-term survival for melanoma patients compared with the first-generation vaccine, new research shows. Interestingly, the benefit of the second-generation vaccine was greater for male patients than female patients. That finding could have important implications for other cancer vaccines, the re . . .